TP53 and endometrium neoplasm: Accordingly: 71% of the PMCH cohort were annotated within the serous histological subtype, whereas only 47% of the PMCL cohort were serous, suggesting copy number variation contributes to the serous phenotype of p53 mutant endometrial tumors.